Campaign India Team
Apr 02, 2014

ADK Fortune wins creative duties of Mankind Pharma

Account moves following multi-agency pitch; brands include ManForce, Addiction

ADK Fortune wins creative duties of Mankind Pharma

Mankind Pharma has appointed WPP's ADK Fortune as its creative agency, following a multi-agency pitch. DDB Mudra was the incumbent.

Besides consumer drugs, the pharmaceutical company owns brands such as ManForce (condoms), Adiction (deo) and PregaNews (pregnancy test kit).

In a statement, Arjun Mukherjee, managing partner, ADK Fortune, said, “We are extremely happy that Mankind Pharma has given us the creative mandate for its entire portfolio. The team looks forward to contributing to the further success and growth of the brand.”

Akashneel Dasgupta, creative head, ADK Fortune, added, “It is an interesting time to come on board Mankind, when the world has suddenly got keener to notice their every move. We are happy to have this mandate.”

Dr. Sanjay Koul, AVP, ManKind Pharma, said, “Looking forward to work with such an energetic and dedicated team. We hope they continue the same services in future as well and keep the good work going thereby making this association fruitful for both of us.”

Source:
Campaign India

Related Articles

Just Published

2 days ago

Onam 2025: Brands blend tradition and storytelling ...

Marking the harvest festival of Onam, brands like JBL India, Lunchbox, JSW MG Motor launch special campaigns highlighting themes of family, tradition, and togetherness.

3 days ago

Open web shapes festive ad strategies as costs climb

As India’s festive season pushes marketing spend to peak levels, shifting consumer journeys on the Open Web are redrawing brand playbooks.

3 days ago

Kempegowda International Airport hits the play ...

It unveils Rhythm of BLR, a sonic identity adapted from Ricky Kej’s anthem, adding sound to brand strategy in transit hubs.

3 days ago

Dentsu appoints bankers to seek buyers for ...

Dentsu is reported to be exploring divestment options including sale of a minority stake to a full sale of its overseas operations.